DeepBio won the CES Innovation Award for pioneering a new milestone in Korean cancer diagnosis A.I. solutions. SEOUL, South Korea, Nov. 20, 2023 /PRNewswire/ -- DeepBio announced today that it has been awarded the CES Innovation Award as...

Deep Bio: An award ceremony was held on July 4th, where Director Byeonggweon Lee from the Korean Ministry of SMEs and Startups (MSS) presented a plaque and expressed confidence in Deep Bio’s potential. SEOUL, SOUTH KOREA (PRWEB) JULY 07,...

[SEOUL, South Korea, Jul. 21, 2022] Lunit, a global provider of AI-powered cancer solutions, announced today that it made its stock market debut on the South Korean KOSDAQ under the ticker “A32813”. Lunit’s initial public offering of...

Deep Bio Presents Research Results of AI-based Cancer Diagnosis and Prognosis at the AACR Annual Meeting 2022 Five abstracts in prostate and breast cancers, Deep Bio’s main research areas, are presented during the online sessions. SEOUL,...